Given this finding, along with the association of SSc with polymorphisms in interferon regulatory factors IRF5 and IRF8 [44, 64], the interferon pathway may be playing a critical role in modulating SSc pathogenesis [65]. This evidence concerns the gene IRF5 and systemic sclerosis.